T he development of large elastic artery stiffening is physiologically related to aging and accelerates atheromatosis in the presence of other risk factors, including diabetes mellitus, hypertension, tobacco consumption, hypercholesterolemia, and heredity. 1-3 Understanding the mechanisms by which large elastic arteries stiffen with age and interventions that reverse this stiffening are thus of major physiological and biomedical importance.
VSMC stiffness was strongly reduced after disassembly of the actin cytoskeleton or inhibition of myosin light chain kinase (MLCK). These data suggest that increased vascular stiffness with aging is at least partly attributable to intrinsic changes in VSMCs. However, the use of in vitro culture conditions can profoundly alter the gene expression program and thereby influence cell phenotype, and the contribution of VSMC intrinsic stiffness to large artery stiffness in vivo has not been addressed so far. Yet this question is clinically relevant because direct pharmacological manipulation of vascular stiffening by control of muscular tone and blood pressure is currently the main therapeutic strategy used to reduce cardiovascular risk. The treatment of large artery stiffening in patients using calcium channel blockers and angiotensin II receptor antagonists reduces arterial stiffness in hypertension. [7] [8] [9] Targeting directly VSMC stiffness may open up new therapeutic perspectives. However, the molecular and cellular mechanisms that control mechanical properties of VSMCs are difficult to assess in an integrated system in vivo.
We have shown previously that inactivation of single cytoskeletal or focal adhesion components of the VSMCs such as desmin or α 1 integrin alters arterial stiffness. 10, 11 However, such inactivation of cytoskeletal genes during embryogenesis is often partially compensated by an increase in other cytoskeleton components. To assess the contribution of VSMCs as a whole in arterial stiffness, we decided to use the model of an inducible smooth muscle cell (SMC)-specific serum response factor (SRF) mutation in the adult mouse. In differentiated VSMCs, SRF is involved in the control of cytoskeletal genes, including SMA, SM myosin heavy chain (SM-MHC), calponins, troponin, dystrophin, or desmin. 12, 13 On the contrary, cytoskeleton-mediated signals play a major role in the regulation of SRF activity on its target genes. 14 In human pathologies, reduced SRF expression has been associated with heart failure, 15 whereas increased SRF expression has been associated with a hypercontractile phenotype in cerebral arteries of Alzheimer patients. 16 In mouse Cre-lox models, cardiac-specific SRF disruption in the adult and postnatal heart induces a rapid progression to dilated cardiomyopathy correlated with a decreased expression of the proteins involved in force generation and transmission as well as with a low level of actin polymerization. [17] [18] [19] SMC-specific inactivation of the SRF gene in mouse embryos 20 results in a severe decrease in actin/intermediate filament bundles in VSMCs, whereas we showed that visceral SMC-specific inactivation of the SRF gene in adult mice leads to a severe motility disorder, resembling chronic intestinal pseudo-obstruction in humans, demonstrating that SRF plays a crucial role in maintaining visceral SM contractility. 21 We have also recently shown a marked reduction in myogenic tone at the level of tail arteries in SMC-specific SRF knockout mice owing to decreased stress-activated channel activity, suggesting that SRF plays a major role in the control of local blood flow in the resistance arteries. 22 Together these observations suggest that exploration of the endogenous mechanical properties of VSMCs may be facilitated using an SRF mutation mouse model. Therefore, to evaluate the role of VSMCs in arterial stiffness, this study was designed to measure SM reactivity in vivo and in vitro, together with the molecular events associated with SRF gain or loss of function in mice. The results provide further support for the hypothesis that VSMC phenotypic modulation affects the elastic properties of large vessels.
Methods

Generation of Inducible SMC-Specific SRF Knockout or Overexpression Mice
The generation of SRF-flex2neo mice and SM22-CreER T2 ki mice has been described previously. 23, 24 Inducible SRF overexpression mice were generated using a transgene CAG-flCAT-SRF in which a mouse SRF cDNA is placed downstream to a floxed cassette containing a chloramphenicol acetyl transferase reporter gene and a polyadenylation signal sequence that terminates transcription. The expression is under the control of a ubiquitous composite promoter made of cytomegalovirus immediate early enhancer and the chicken β-actin promoter. It is only in the presence of Cre, which excises the chloramphenicol acetyl transferase-PolyA sequence, that SRF can be expressed. CAG-flCAT-SRF transgenic mice were crossed with the SM22-CreER T2 (ki) mice to generate SM22a-CreER T2 (ki)/CAG-flCAT-SRF double transgenic mice. To generate SM-specific SRF knockout or overexpression, 3-to 6-month-old SRF-flex2neo/SRF-flex2neo-SM22CreER T2 ki/+SM-specific knockout of SRF (SRF SMKO mice) or CAG-flCAT-SRF/SM22-CreER T2 (ki)/+SM-specific overexpression of SRF (SRF SMTG ) mice were injected IP with 1 mg of tamoxifen (TAM; Sigma) in 100 μL of peanut oil for 3 days. All control (SRF-flex2neo/SRF-flex2neo, SM22-CreER T2 (ki), and CAG-flCAT-SRF littermates) mice were systematically injected with TAM to normalize for any effects owing to TAM itself. All experiments were performed in mice 15 days after TAM injection with the exception of microarray assay, which was performed at an earlier stage (8 days). All procedures were performed in accordance with institutional guidelines for animal experimentation. 
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Statistical Analysis
All values are expressed as mean±SEM. Differences between groups were assessed with paired or unpaired Student t tests. We compared the diameter (Dia)-pressure curves, the distensibility (Dist)-pressure curves, and the incremental elastic modulus (Einc)/wall stress (WS) curves using the median values of the common range of either arterial pressure for Dia and Dist or Einc for wall stress. Arterial mechanical parameters and E max or pD2 values were analyzed using 1-way ANOVA, and the Fisher post hoc test was used for intergroup comparisons. Differences were considered significant at values of P<0.05. The methods concerning blood pressure and echo-tracking measurements, vascular reactivity analysis, histological procedures, electron microscopy analysis, microarray analysis, quantitative reverse transcription-polymerase chain reaction assay, and Western blotting analysis are presented in detail in the Online Data Supplement.
Results
SMC-Specific Inactivation or Overexpression of SRF Gene in Arteries
SRF SMKO mice were injected IP with TAM to activate Cre-ER T2 -mediated VSMC-specific excision of SRF exon 2. We confirmed that SRF expression was reduced, by 51% at the mRNA level and 72% at the protein level, in the aorta of SRF SMKO mice compared with controls at day 15 post-TAM ( Figure 1 ). This partial SRF reduction can be explained by the presence of other cells expressing SRF in the aorta, such as fibroblasts and endothelial cells in which inactivation of SRF in SMCs could induce an upregulation of SRF. The number of SRF-positive nuclei and the staining intensity in immunofluorescence experiments was significantly reduced (60% and 76% of control level, respectively) in SMCs. In SRF SMTG mice, a mild-overexpression of SRF was observed at mRNA (2×) and at protein (1.7×) levels (Online Figure I) .
Arterial Blood Pressure and Echo-Tracking Analysis
Mean values of hemodynamic and arterial parameters are provided in Table 1 . Systolic arterial pressure in conscious SRF SMKO mice was lower than in control mice, whereas heart rate was similar in both groups. By contrast, systolic arterial pressure was similar in SRF SMTG and control mice. The mean Dia and Dist within the 76-to 92-mm Hg range of arterial pressure (AP; MDia 76-92 or MDist 76-92 ) were calculated from the Dia/AP curves (data not shown) and Dist/AP curves shown in Figure  2A through 2C. MDia 76-92 was not different between SRF SMKO and control mice but MDist 76-92 was increased in SRF SMKO mice compared with control mice. The Einc/WS curve in SRF SMKO and control mice is shown in Figure 2B . The mean WS within the 400-to 1200-kPa range of Einc (MWS 400-1200 ) in SRF SMKO mice was significantly higher than in control mice. Thus, SRF SMKO carotid artery (CA) has a higher elasticity than that of control mice. Dia/AP, Dist/AP, and Einc/WS curves in SRF SMTG and control mice were not significantly different ( Figure 2C and 2D).
Morphological and Histological Analysis of the Tunica Media
There were no observed differences between SRF SMKO and control mice in terms of carotid collagen, elastin and fibronectin contents, density and expression, or for VSMC nuclear density (Table 1; Figure 3 ). Immunofluorescence analysis for Ki67 antigen and cleaved caspase-3 showed no VSMC proliferative and apoptotic activity (data not shown). Histological analysis indicated that the carotid media cross-sectional area (MCSA) and thickness of SRF SMKO were significantly lower than those of control mice (Table 
Vascular Reactivity and eNOS Expression
Intact Rings from Aorta, CA, and Mesenteric Artery
No difference in contraction induced by phenylephrine was observed between SRF SMKO and control aortic or carotid rings, whereas maximal contraction was significantly lower in mesenteric rings ( Table 2 ). Aortic rings from SRF SMKO presented a lesser maximal relaxation to acetylcholine (ACh), whereas N-nitro-l-arginine methyl ester totally abolished the ACh-induced relaxation in the 2 groups ( Figure 4A ). The maximal relaxations induced by ACh and sodium nitroprusside (SNP) were similar in carotid rings of the 2 groups, whereas the sensitivity to ACh and SNP was lower in SRF SMKO than in control groups. No changes were observed in ACh-and SNP-induced relaxation in mesenteric rings.
Contraction induced by phenylephrine was significantly higher in aortic, carotid, and mesenteric rings of SRF SMTG compared with control intact rings. In SRF SMTG mice, the maximal relaxation induced by ACh or SNP was similar compared with control groups in carotid and mesenteric rings, whereas the maximal relaxation induced by ACh was significantly reduced in aortic rings.
Western blot analysis showed that total-eNOS and phospho-eNOS were significantly increased in the aorta from SRF SMKO compared with that from control mice (221% and 184% of control level, respectively; Figure 4B ). Immunohistological analysis confirmed that the increased eNOS signal after VSMC-specific inactivation of SRF came from the endothelial cells ( Figure 4C and 4D). Total-eNOS and phospho-eNOS were not modified in SRF SMTG mice (Online Figure IC and ID).
Deendothelialized Aortic Rings
The absence of endothelium led to a 37% reduction of phenylephrine-mediated contraction in SRF SMKO compared with control rings (E max , 9.5±0.9 versus 15.1±2.0 mN; P<0.05; Figure 5A ). Similar results were observed in response to KCl between SRF SMKO and control rings (E max , 2.5±0.4 versus 5.5±0.5 mN; P<0.001; Figure 5B ). The relaxation induced by SNP was also significantly lower in SRF SMKO than in control aortic rings ( Figure 5C ). Relaxation induced by 8-Br-cGMP was significantly reduced in aortic rings from SRF SMKO compared with those of control mice ( Figure 4E ), whereas the rings precontracted by phenylephrine were completely relaxed by papaverine in both SRF SMKO and control rings ( Figure 4F ).
Downregulation of Cytoskeletal Proteins and Regulators of Contraction
Global changes in gene expression of the aortas were assessed using Affymetrix MO430.2 chips at an early stage (8 days post-TAM) preceding the manifestation of severe pathological alterations. Gene Ontology term enrichment analysis for cellular component annotations revealed that downregulated genes in the SRF SMKO mice were enriched in terms primarily related to cytoskeleton, notably actin filaments, and focal adhesions, whereas the upregulated gene annotations were enriched in terms related to the extracellular region and the cell membrane. Biological Kyoto Encyclopedia of Gene and Genome pathways related to cell adhesion, SM contraction, and actin filament organization were over-represented in downregulated genes, whereas immune response, cell adhesion, and signaling processes were enriched in upregulated genes (Online Figure Tables III and VII) . Many endothelial cell-enriched genes were upregulated in response to SMCspecific SRF invalidation (Online Tables VIII).
IIIA and IIIB; Online
We confirmed by quantitative polymerase chain reaction, both in aorta and CA, that the loss of SRF in VSMCs decreased the mRNA levels of genes involved in the core components of the actomyosin complex, cytoskeleton, and cell adhesion (Online Figure IIIC) . Western blot and immunofluorescence staining analysis indicated that the total level of the following proteins; MLC, MLCK, myosin phosphatase-targeting subunit 1 (MYPT1), 17-kDa protein kinase C-potentiated inhibitory protein of PP1 (CPI-17), SMA, β-actin, desmin, α v -α 5 -, and β 3 -integrin; was decreased in SRF SMKO mice ( Figure 6 ), in agreement with the downregulation of corresponding mRNAs. One exception concerned SM-MHC, for which no significant decrease in protein level was observed in contrast to the downregulation of the mRNA, suggesting that protein stability extended beyond the period studied here. Similarly, the decrease in protein level of calponin, an actin-, and calmodulin-binding protein, was not significant at this stage. The mRNA and protein levels of RhoA were not changed in the mutant mice compared with control mice. The total level and the phosphorylation ratio of caldesmon, a protein involved in actin-myosin interaction in VSMCs, was not changed in the mutant mice nor was the ratio of phospho-MLCK/ MLCK and phospho-MYPT1/MYPT1. However the ratio of p-CPI-17/CPI-17, an inhibitor of MYPT1, was increased significantly to 300% of control levels in mutant mice. In agreement with the latter observation, the pMLC/MLC ratio was increased to 349% of control levels in mutant mice. In SRF SMTG mice, 15 days after TAM injection, inducible mildoverexpression of SRF in VSMCs increased the mRNA levels of some SRF target genes involved in the core components of the actomyosin complex (such as SMA, SM-MHC, MLC, β-actin) and cytoskeleton (filamin C, vinculin) in CA. There was no increase in the expression of other SRF target genes such as α 1 -, α v -, and β 1 -integrins (Online Figure IC) . Western blot confirmed the slight increase in SM-actin and SM-MHC expression (Online Figure ID ).
Discussion
The present study investigated the in vivo consequences of VSMC phenotypic modifications induced by SRF gene inactivation and overexpression on the mechanical and structural properties of large arteries in mice. SRF inactivation in VSMCs results in a decrease in arterial vascular tone and carotid stiffness in adult mice associated with an impairment of the VSMC response to nitric oxide. Our results highlight the important contribution of VSMCs to arterial stiffness in vivo. We have shown that SRF gene inactivation in VSMCs is directly linked to the downregulation of a series of genes coding for the proteins involved in the SM contractile phenotype, such as components of the contractile apparatus, mainly SMA and MLC and regulators of contraction such as MLCK, MYPT1, and CPI-17, and the structural cytoskeleton. In contrast, inducible overexpression of SRF had no effect on arterial blood pressure and Dist of the CA 15 days after TAM injection. This finding may be related to the absence of upregulation of genes involved in cell-matrix interactions, such as integrins, in SRF SMTG mice. Our results indicate that the effect of SRF gene inactivation is more deleterious than the mild overexpression of this gene.
Inactivation of SRF in VSMCs decreased the mRNA levels of SM-MHC but not the protein level in the aorta and CA. Although SM-MHC is the definitive marker of the SM contractile phenotype, the finding that SM-MHC protein level is preserved could be linked to a different turn-over rate or a protection by chaperon proteins. Although the half-life of SM-MHC is almost identical to that of SM-α-actin in cell culture, the situation could be very different in vivo. For example, in skeletal muscle, it has been reported that the thin filament (actin-containing) components are the privileged targets of ubiquitin ligase (degradation of proteins by the proteosome) compared with the thick (myosin-containing) filament components during fasting. 25 Other systems, such as microRNA-mediated inhibition of protein synthesis, could contribute to protein stability. Whereas SM-MHC, SM-α-actin, and calponin are not direct targets of miRs-143 and -145, it has been shown that many targets of miRs-143 and -145 are genes involved in cytoskeletal remodeling, particularly actin filament organization and SRF activation (such as MRTF-B and KLF4). 26 It is also known that SRF regulates the expression of some microRNAs, such as miR-143 and miR-145, 14 and so the altered expression of some Data represent mean±SEM. Ach indicates acetylcholine; E max , maximal efficiency; n, number of rings; pD2, negative logarithms of the concentration required to produce 50% contraction in response to PE or 50% relaxation in response to Ach; SNP, sodium nitroprusside; SRF SMKO , smooth muscle-specific knockout of SRF; and SRF SMTG , smooth muscle-specific overexpression of SRF. *P<0.05, **P<0.01, and ***P<0.001 vs control mice; °P<0.05, °°P<0.01, and °°°P<0.001 vs SRF SMKO mice.
microRNAs, owing to SRF loss, may have influenced protein stability. Alternatively, given the relative preservation of SM-MHC, it is reasonable to hypothesize that the vasoreactivity change in SRF KO mice is a consequence of both SM contractile protein-dependent and protein-independent SRF effects.
The decrease in proteins downstream to SRF, related to stress responses and cytoskeletal organization, largely explains the impairment in contraction/relaxation. This is in agreement with the fact that increased SRF expression was associated with a hypercontractile phenotype in cerebral arteries of Alzheimer patients 16 and that enhanced SRF binding to the promoter of the SM-MLCK gene, owing to a 12-base pair insertion adjacent to the SRF binding site, was associated with the VSMC contractile phenotype in spontaneously hypertensive rats. 27 These results not only confirm the molecular events previously reported for SRF depletion in mice [16] [17] [18] [19] 28 but also extend these observations to include the 2 major physiological aspects of vascular muscle reactivity, namely contraction and relaxation, both in vivo and in vitro. The data strengthen the hypothesis that changes in the intrinsic phenotype of VSMCs affect the elastic properties of large vessels. On the contrary, inducible mild overexpression of SRF can increase expression of some SRF targets, such as SMA and SM-MHC, which are not accompanied by an increase in integrin expression. This finding likely explains the lack of increased arterial stiffness, which requires increased cell-matrix attachments in addition to the activation of VSMCs.
Alteration of VSMC Phenotype Reduces the Stiffness of Large Arteries
Stiffening of the aorta and other central arteries is considered to be an important risk factor for increased cardiovascular morbidity and mortality. Arterial mechanical properties are dependent on the amount and density of ECM proteins and the spatial organization of cell-matrix interactions. 4, 10, 29 Recently, Qiu et al 6 reported that increased aortic stiffness in aging is attributable to not only changes in the ECM but also increased intrinsic stiffness of the VSMCs. Specific inactivation of SRF in VSMCs provides an opportunity to examine the contribution of VSMC differentiation to arterial stiffness in vivo. The slight reduction in systolic arterial pressure in conscious SRF SMKO may be related to the decrease in vascular tone and occurred in parallel with a decrease in arterial thickness owing to VSMC hypotrophy. There are limitations to the calculation of arterial stiffness using values of MCSA obtained on fixed tissue. The determination of Einc and circumferential wall stress requires the value of arterial thickness or MCSA during the cardiac cycle. The MCSA is a much more appropriate parameter than arterial thickness because the former is constant during the cardiac cycle. 29, 30 We observed by electron microscopy that VSMCs had lost part of their connections to the ECM in SRF SMKO mice. This defect could be linked primarily to the decrease in several integrins, such as α 5 , α 8 , α v , β 1 , and β 3 , in the mutant mice. The medial hypotrophy, confirmed by the measurement of media thickness and interlamellar dimensions, could reflect the consequence of less cytoskeleton and weaker interactions between VSMCs and ECM which normally protect the vascular architecture.
In SRF SMKO mice, the concomitant shift of the Dist-AP curves and Einc/WS curves corresponds to an increase in elasticity, at both functional (global behavior of artery) and structural levels (intrinsic mechanical properties of the arterial wall). The physiological relevance of this arterial wall remodeling has been tested using chronic infusion of angiotensin II (data not shown). However, the effects of angiotensin II could be only tested for 14 days because the SRF SMKO mice died around 3 weeks after induction owing to intestinal obstruction. 21 Despite equivalent blood pressure elevation in control and SRF SMKO mice, this duration was insufficient to reveal whether SRF inactivation delays arterial stiffening in the context of hypertension.
The mechanical circumferential stresses at MAP (data not shown) were not different between SRF SMKO and control mice. This suggests that the differences in reactivity and gene and protein expression levels are likely not explained by differences in cellular mechanical environment. It has been suggested that some integrins, such as α 1 , α 5 , and α v , may regulate mechanical properties of the arterial wall via phenotypic changes and the number of focal attachment structures between cells and ECM. 11, [31] [32] [33] At the level of the arterial wall, the number of attachment points increases with the degree of contraction of VSMCs leading to wall stiffening. 4 In SRF SMKO , the reduced expression of α 5 , α v , α 1 , and β 3 subunits at mRNA and protein levels probably leads to decreased functional attachments sites. Regarding the structural composition of the artery, no significant change was observed in collagen/elastin contents and density or in protein levels of different collagen types, fibronectin, and metalloproteinases in the aorta and carotid arteries of SRF SMKO mice 15 days after SRF deletion. Thus, the increased elasticity observed in our mutant mice is likely owing to alterations in contractile apparatus, cytoskeletal organization, and cell-matrix interactions. In agreement with this, the level of contractile proteins, such as SMA, MLC, and contraction regulators of MLCK, myosin light chain phosphatase (MLCP; MYPT1 and CPI-17), was reduced. Although the increase in phosphorylation of MLC and CPI-17 may partly blunt the reduced cell contractility, such a compensatory mechanism is inefficient in regulating arterial elasticity.
Alteration of VSMC Phenotype Reduces Muscular Tone
We have reported previously that loss of SRF in colonic muscle results in a severely decreased contractile response to both electric field and cholinergic stimulation. 21 In the present study, we showed that SRF inactivation in VSMCs leads to an alteration in vascular reactivity after stimulation by different pharmaceutical agents in the arteries of SRF SMKO mutant mice. In the presence of endothelium, there was a decreased vasodilator response in elastic arteries (aorta and CA), whereas a decrease in contractile response was found in mesenteric arteries. The unchanged relaxation in mesenteric arteries may be explained by a lower level of precontracted state. In aorta, the hypercontractile effect of deendothelialization is observed only in control mice. This result suggests that the modulatory role of endothelium on vascular tone is modified in the mutant and partially compensates for the intrinsic VSMC contractile defect.
SM myosin, unlike striated muscle myosin, requires phosphorylation at ser 19 of the MLC to reach significant levels of actin-activated myosin ATPase activity. The phosphorylation of MLC is primarily controlled by MLCK, an SRF target 34 that can be activated in a Ca 2+ -dependent and Ca 2+independent manner. The dephosphorylation of MLC is catalyzed by MLCP composed of a catalytic subunit, pp1c delta, a regulatory subunit MYPT1 and a small 20-kDa subunit of unknown function. 35 MLCP activity can be regulated by the dual function protein, MYPT1, that functions either as an activator of MLCP by targeting the MLCP complex to its substrate MLC, 36 or as an MLCP inhibitor when MYPT1 is phosphorylated on 1 or both of its 2 phosphorylation sites (T696 and T853). 37 Another MLCP inhibitor is CPI-17 that acts as an MLCP pseudosubstrate when phosphorylated, thereby competing with MLC. Our results indicate that MYPT1 and CPI-17 are potential SRF targets because mRNA and protein levels of MYPT1 and CPI-17 are decreased in SRF SMKO mutant mice. The phosphorylation levels of MLCK, MYPT1, and CPI-17 proteins influence the contraction/relaxation of VSMCs. We observed that MLCK and MYPT1 phosphorylation is not significantly altered in the mutant mice. In contrast, the ratio of p-CPI-17/CPI-17 and p-MLC/MLC is increased about 3-fold compared with control mice. The downregulation at the protein level of MLC and MLCK may represent a mechanism to explain the defective contractile response in the arteries of the SRF SMKO , whereas the increase in MLC phosphorylation, together with the maintenance of total protein and phosphorylation levels of caldesmon as well as the preservation of the SM-MHC protein level in mutant mice at this stage, could partially compensate this reduction in contractility. The downregulation at the protein level of MYPT1 results in a decrease in MLCP activation and thereby may reduce the relaxation. The increase in CPI-17 phosphorylation may also contribute to impair relaxation. These regulatory pathways form a network that tightly regulates MLCP and, therefore, has a significant impact on the balance between contraction and relaxation. Finally, the decrease in cytoskeletal proteins, such as desmin, filamin C, and β-actin, in mutant mice is likely to result in deficient cell structural organization and force transmission.
It is well known that nitric oxide produced by eNOS in the endothelium plays a role in the regulation of vascular tone. 38, 39 L-NAME, an eNOS inhibitor, totally abolished the relaxation induced by ACh in aortic rings of control and mutant mice, suggesting that endothelium-derived nitric oxide is functioning in both groups. In fact, eNOS activity is increased in SRF SMKO mice. This increase in eNOS expression may be related to the increase in several transcriptional factors and cofactors, such as GATA2, Fli1, and Klf2, in agreement with previous reports. [40] [41] [42] Altogether, these results indicated that the defect in VSMC-dependent tone in terms of contraction and relaxation is a result of altered intrinsic properties of VSMCs and the downstream NO signaling, as shown by the lower efficiency of SNP and 8-Br-cGMP to relax aortic rings of mutant mice. The paradoxical decrease in vasodilator responses may be also related to increased eNOS expression in the endothelium as previously reported in transgenic aorta overexpressing eNOS. 43, 44 In SRF SMTG mice, the increased contractile response to drug stimulation in vitro compared with control mice also argues for a regulatory role of SRF in vasomotor tone. This increased contractility could be related to slight increases in contractile proteins, such as SMA and SM-MHC. However, in in vivo conditions, the increased vascular reactivity did not result in increased arterial stiffness because the basal level of activation of VSMC was probably too low and the extra ability of contraction in SRF SMTG was not solicited. We can anticipate that arterial stiffness may be exaggerated in SRF SMTG with aging owing to this higher level of contraction.
Conclusion
This SMC-specific SRF conditional invalidation and overexpression models are valuable tools allowing the identification of altered regulatory processes controlling VSMC plasticity. The increased arterial elasticity in the SRF SMKO mutant mouse is probably the consequence of the reduction in contractile proteins and attachment sites. The pathophysiological relevance of SRF has been previously established in maintaining a normal actin cytoskeleton during development. In view of our new findings, we can suggest that the regulatory role of SRF is crucial in the function and structure of elastic and resistance arteries and their remodeling during aging.
What Is Known?
• Vascular smooth muscle cells (VSMCs) and the extracellular matrix are 2 major determinants of arterial stiffening. • Intrinsic stiffening of VSMCs has been shown to increase with age. • Serum response factor (SRF) is a major transcription factor of VSMCs.
What New Information Does This Article Contribute?
• SRF gene inactivation reduces vasoconstriction in mesenteric arteries and increases intrinsic elasticity in large arteries. • The gain-and loss-of-function studies of SRF provide evidence for the contribution of VSMCs to arterial stiffness in vivo in the absence of significant change in collagen/elastin content. • Alteration of arterial stiffness and contraction/relaxation coupling in SRF-invalidated mice is linked to the downregulation of certain genes involved in the contractile apparatus, cytoskeletal organization, and in cell-matrix interactions.
SRF, a major transcription factor in VSMCs, is essential to maintain a normal actin cytoskeleton in vascular wall during development. Whether the loss of SRF in VSMCs has a consequence on vascular tone and arterial stiffness in the adult is unknown. Using smooth muscle cell-specific SRF knockout mice (SRF SMKO mice), we show that SRF gene inactivation reduces muscular tone and the stiffness of large arteries, providing the in vivo evidence for the contribution of VSMCs to arterial stiffness in the absence of significant change of collagen/elastin content. We also demonstrate that components of the contractile apparatus and regulators of contraction as well as cytoskeletal proteins and integrins are reduced in SRF SMKO mice. Our findings bring new insight into the mechanisms controlling the pattern of gene expression turning VSMCs into potent orchestrators of arterial stiffening. The lack of change in smooth muscle myosin heavy chain together with reduced smooth muscle α-actin suggests both contractile protein-dependent and protein-independent effects. Our results point toward transcription factors and miR expression-induced VSMC phenotypic switching as potential research and therapeutic strategies for prevention of arterial stiffening with age.
Novelty and Significance
